Androgen deprivation therapy and acute kidney injury in patients with prostate cancer undergoing definitive radiotherapy.
Michael V ShererRishi DekaMia A SalansTyler J NelsonPaige SheridanBrent S RosePublished in: Prostate cancer and prostatic diseases (2021)
Our findings confirm that use of ADT is associated with an increased risk of AKI in patients undergoing definitive RT for prostate cancer. Clinicians should be alert to the potential for renal dysfunction in this population.